centrally acting muscle relaxants

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:drug
gptkbp:cautions	elderly patients patients with history of substance abuse patients with liver impairment
gptkbp:compatibleWith	gptkb:myasthenia_gravis direct muscle injury
gptkbp:contraindication	hypersensitivity severe liver disease
gptkbp:drugInteraction	gptkb:beer gptkb:benzodiazepines opioids antidepressants
gptkbp:duration	varies by drug
gptkbp:eliminatedIn	gptkb:kidney
gptkbp:example	gptkb:metaxalone gptkb:chlorzoxazone gptkb:baclofen gptkb:diazepam gptkb:carisoprodol gptkb:cyclobenzaprine gptkb:methocarbamol gptkb:orphenadrine gptkb:tizanidine
https://www.w3.org/2000/01/rdf-schema#label	centrally acting muscle relaxants
gptkbp:mechanismOfAction	act on central nervous system
gptkbp:metabolism	liver
gptkbp:monitors	liver function mental status renal function
gptkbp:onset	varies by drug
gptkbp:overdoseSymptoms	death coma respiratory depression
gptkbp:pregnancyCategory	varies by drug
gptkbp:prescribes	gptkb:physician
gptkbp:regulates	prescription only
gptkbp:riskFactor	addiction potential impaired driving CNS depression
gptkbp:routeOfAdministration	oral intravenous
gptkbp:sideEffect	dizziness fatigue drowsiness
gptkbp:usedFor	muscle spasms muscle spasticity
gptkbp:bfsParent	gptkb:Muscle_Relaxants,_Central gptkb:baclofen
gptkbp:bfsLayer	7